ProfileGDS4718 / 242578_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 89% 87% 82% 86% 88% 84% 88% 82% 84% 84% 84% 85% 79% 86% 85% 82% 80% 86% 85% 96% 82% 83% 80% 81% 87% 81% 84% 96% 87% 90% 84% 87% 86% 83% 87% 84% 89% 83% 83% 79% 83% 91% 87% 87% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.0044689
GSM549102patient 115, normal, homogenized [OPG study]8.7501987
GSM549104patient 119, normal, homogenized [OPG study]8.1302982
GSM549108patient 138, normal, homogenized [OPG study]8.4671686
GSM549119patient 077, normal, homogenized [OPG study]8.9046988
GSM549133patient 032, cancer, homogenized [OPG study]8.5275884
GSM549139patient 042, cancer, homogenized [OPG study]8.8573188
GSM549099patient 107, normal, homogenized [OPG study]8.0085882
GSM549109patient 139, normal, homogenized [OPG study]8.2502284
GSM549110patient 046, normal, homogenized [OPG study]8.271284
GSM549114patient 063, normal, homogenized [OPG study]8.468484
GSM549122patient 082, normal, homogenized [OPG study]8.4803685
GSM549134patient 033, cancer, homogenized [OPG study]7.7967279
GSM549136patient 036, cancer, homogenized [OPG study]8.6266786
GSM549140patient 044, cancer, homogenized [OPG study]8.5778885
GSM549111patient 047, normal, homogenized [OPG study]8.1563782
GSM549113patient 057, normal, homogenized [OPG study]7.955380
GSM549132patient 031, cancer, homogenized [OPG study]8.6127586
GSM549137patient 038, cancer, homogenized [OPG study]8.45285
GSM549142patient 047, cancer, homogenized [OPG study]10.10896
GSM549100patient 110, normal, homogenized [OPG study]8.0500982
GSM549107patient 135, normal, homogenized [OPG study]8.2271983
GSM549115patient 068, normal, homogenized [OPG study]8.0019780
GSM549116patient 072, normal, homogenized [OPG study]8.0589781
GSM549120patient 078, normal, homogenized [OPG study]8.8139587
GSM549131patient 030, cancer, homogenized [OPG study]8.0794181
GSM549118patient 074, normal, homogenized [OPG study]8.4141484
GSM549129patient 027, cancer, homogenized [OPG study]10.173296
GSM549123patient 088, normal, homogenized [OPG study]8.8116987
GSM549124patient 006, cancer, homogenized [OPG study]9.0636990
GSM549126patient 015, cancer, homogenized [OPG study]8.2572884
GSM549128patient 025, cancer, homogenized [OPG study]8.7775187
GSM549103patient 117, normal, homogenized [OPG study]8.502486
GSM549117patient 073, normal, homogenized [OPG study]8.2269683
GSM549138patient 041, cancer, homogenized [OPG study]8.7984587
GSM549141patient 045, cancer, homogenized [OPG study]8.4135984
GSM549130patient 028, cancer, homogenized [OPG study]8.8641289
GSM549101patient 111, normal, homogenized [OPG study]8.2172783
GSM549105patient 128, normal, homogenized [OPG study]8.1862883
GSM549106patient 134, normal, homogenized [OPG study]7.8723779
GSM549112patient 048, normal, homogenized [OPG study]8.277283
GSM549125patient 011, cancer, homogenized [OPG study]9.3718591
GSM549127patient 024, cancer, homogenized [OPG study]8.7281487
GSM549135patient 035, cancer, homogenized [OPG study]8.7723387